CDC Elevates Ebola Response to Highest Level

The Centers for Disease Control and Prevention announced on June 26, 2026 that it has upgraded its operational response to the Ebola virus disease outbreak in the Democratic Republic of the Congo (DRC) to Level 1, the agency’s most urgent activation level. The decision follows a rapid increase in the number of cases and the expanding geographic spread of the virus, which now includes a smaller cluster of cases across the border in Uganda.

Satish Pillai, the CDC’s Ebola response incidence manager, explained that elevating the response level reflects the urgency, scale, and complexity of the outbreak. By moving to Level 1, the CDC can bring additional resources, staff, and expertise to coordinate with international partners and local health authorities, ensuring a more robust operational support structure.

The World Health Organization (WHO) has reported more than 1,000 Ebola cases and over 260 deaths since the outbreak began in May. The outbreak is linked to the Bundibugyo strain of the virus, which presents particular challenges because no approved therapeutics or vaccines exist for this strain. Despite these hurdles, the CDC emphasizes that the risk of the virus spreading to the United States remains low.

U.S. officials highlighted that stringent surveillance and containment measures, along with rapid diagnostic capabilities, help keep the national risk minimal. CDC’s enhanced response plan focuses on supporting the DRC and Ugandan health systems, providing guidance on infection control, and facilitating the safe transport of patients if needed.

Health professionals stress that while there is no specific cure for Ebola, supportive care—such as fluid replacement and management of symptoms—has saved lives. The agency continues to monitor the situation closely, ready to adjust its response as new information emerges.

In summary, the CDC’s highest‑level activation signals a strong commitment to combatting the Ebola outbreak abroad while maintaining vigilance at home. The agency’s coordinated effort underscores the importance of global health partnerships and the preparedness of U.S. public health infrastructure to address emerging infectious diseases.